Fellowship · Houston, TX
Sponsored by University of Texas Medical Branch Hospitals
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,452 citations · Prajnan Das
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 1,863 citations · Yinghong Wang
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology · 2022 · 1,038 citations · Yinghong Wang
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 501 citations · Prajnan Das
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 179 citations · Prajnan Das
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
The New England journal of medicine · 2025 · 127 citations ·
Profiling the human intestinal environment under physiological conditions.
Nature · 2023 · 365 citations · George Triadafilopoulos
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 415 citations · Yinghong Wang